|
INMB
|
INmune Bio Inc.
|
US
|
NASDAQ
|
|
IOVA
|
Iovance Biotherapeutics, Inc.
|
US
|
NASDAQ
|
|
IPHA
|
Innate Pharma S.A.
|
US
|
NASDAQ
|
|
JNCE
|
Jounce Therapeutics, Inc.
|
US
|
NASDAQ
|
|
LAB
|
Standard BioTools Inc.
|
US
|
NASDAQ
|
|
LCTX
|
Lineage Cell Therapeutics, Inc.
|
US
|
AMEX
|
|
MBIO
|
Mustang Bio, Inc.
|
US
|
NASDAQ
|
|
MNK
|
Mallinckrodt plc
|
US
|
AMEX
|
|
MRKR
|
Marker Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NBTX
|
Nanobiotix S.A.
|
US
|
NASDAQ
|
|
NEXI
|
NexImmune, Inc.
|
US
|
NASDAQ
|
|
NKTX
|
Nkarta, Inc.
|
US
|
NASDAQ
|
|
NXTC
|
NextCure, Inc.
|
US
|
NASDAQ
|
|
ONCR
|
Oncorus, Inc.
|
US
|
NASDAQ
|
|
ONCS
|
OncoSec Medical Incorporated
|
US
|
NASDAQ
|
|
ORIC
|
Oric Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
PDSB
|
PDS Biotechnology Corporation
|
US
|
NASDAQ
|
|
PYXS
|
Pyxis Oncology, Inc.
|
US
|
NASDAQ
|
|
REPL
|
Replimune Group, Inc.
|
US
|
NASDAQ
|
|
SABS
|
SAB Biotherapeutics, Inc.
|
US
|
NASDAQ
|